These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 27804866)

  • 1. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
    Takebe N; Harris PJ; Warren RQ; Ivy SP
    Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway.
    Wang X; Zhang N; Huo Q; Sun M; Dong L; Zhang Y; Xu G; Yang Q
    Tumour Biol; 2014 Nov; 35(11):10805-13. PubMed ID: 25077927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
    Kakarala M; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
    Alonso S; Jones RJ; Ghiaur G
    Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
    Oren O; Smith BD
    Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
    Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
    Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
    Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery approaches to target Wnt signaling in cancer stem cells.
    Curtin JC; Lorenzi MV
    Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy].
    Ma Y; Wang HX
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):881-5. PubMed ID: 21223793
    [No Abstract]   [Full Text] [Related]  

  • 14. Notch signaling in cancer stem cells.
    Wang J; Sullenger BA; Rich JN
    Adv Exp Med Biol; 2012; 727():174-85. PubMed ID: 22399347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
    Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
    Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells: the promise and the potential.
    Ajani JA; Song S; Hochster HS; Steinberg IB
    Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
    Shan NL; Shin Y; Yang G; Furmanski P; Suh N
    Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting embryonic signaling pathways in cancer therapy.
    Harris PJ; Speranza G; Dansky Ullmann C
    Expert Opin Ther Targets; 2012 Jan; 16(1):131-45. PubMed ID: 22239436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.